Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approach.

The Lancet regional health. Western Pacific·2026

Same author

Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS).

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025

Same author

Development of three-step holistic care pathways to detect and manage comorbidities in patients with atrial fibrillation: the Horizon 2020 EHRA-PATHS consortium.

European heart journal open·2025

Same author

Adverse Effect of Ventricular Rate Regularization Pacing in Biventricular Cardiac Resynchronization Therapy.

Journal of cardiovascular electrophysiology·2025

Same author

Impacts of viral respiratory infections on segments of fatal out-of-hospital cardiac arrests.

Postgraduate medical journal·2025

Same author

Postmortem Removal of Submuscularly Placed Subcutaneous Implantable Cardioverter Defibrillator in the Obese.

Pacing and clinical electrophysiology : PACE·2025

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Bone marrow stem cell therapy for myocardial angiogenesis.

Hung-Fat Tse¹, Kai-Hang Yiu, Chu-Pak Lau

¹Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, China. hftse@hkucc.hku.hk

Current Vascular Pharmacology

|April 14, 2007

Summary

Adult bone marrow stem cells show promise for treating coronary artery disease (CAD) by improving heart function through neovascularization. Further research is needed to clarify optimal strategies and long-term outcomes for this therapy.

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Experiment Videos

Last Updated: Jul 15, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Area of Science:

Cardiology
Regenerative Medicine
Stem Cell Therapy

Background:

Coronary artery disease (CAD) is a leading cause of death globally, particularly in developing nations.
Severe CAD leads to myocardial ischemia, cardiomyocyte loss, and heart failure, necessitating novel therapeutic strategies.
Adult bone marrow (BM)-derived stem cells have shown potential for inducing neovascularization and improving cardiac function in experimental models.

Purpose of the Study:

To investigate the potential of adult bone marrow stem cell transplantation for treating severe coronary artery disease (CAD).
To explore the therapeutic angiogenesis and myocardial regeneration capabilities of bone marrow-derived stem cells in ischemic heart conditions.

Main Methods:

Review of experimental studies and initial clinical trials on bone marrow stem cell therapy for heart disease.
Discussion of challenges in stem cell identification, purification, and expansion for myocardial regeneration.

Main Results:

Experimental studies indicate that bone marrow stem cells can promote neovascularization in ischemic myocardium and improve heart function.
Early clinical trials suggest potential benefits of bone marrow therapy for therapeutic angiogenesis in CAD patients.

Conclusions:

Bone marrow stem cell therapy presents a promising approach for managing refractory heart diseases, including CAD.
Further rigorously designed, randomized clinical trials are essential to establish the long-term safety, optimal timing, and treatment strategies for bone marrow-derived stem cell therapy in CAD.